Thierry Landre

机构：Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Paris-Ouest, Hôpital René-Muret · ORCID：0000-0003-0967-1276

发表论文 59 篇 · 总被引 798 次 · h-index 15

代表论文

• Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials (2021 · Cancer Immunology Immunotherapy · 被引 95)
• Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis (2024 · ESMO Open · 被引 90)
• Immune Checkpoint Inhibitors for Patients Aged ≥ 75 Years with Advanced Cancer in First- and Second-Line Settings: A Meta-Analysis (2020 · Drugs & Aging · 被引 39)
• First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation (2020 · Journal of Cancer Research and Clinical Oncology · 被引 22)
• Impact on All-Cause and Cardiovascular Mortality Rates of Coronary Artery Calcifications Detected during Organized, Low-Dose, Computed-Tomography Screening for Lung Cancer: Systematic Literature Review and Meta-Analysis (2021 · Cancers · 被引 20)
• Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-Analysis (2021 · Cancers · 被引 19)